Navigation Links
Prostate cancer vaccines more effective with hormone therapy
Date:7/9/2008

PHILADELPHIA Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research.

Philip M. Arlen, M.D., director of the Clinical Research Group for the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, at the National Cancer Institute, said the findings have important implications for guiding treatment decisions for prostate cancer patients.

"Vaccines, if and when they are approved, can be safely and effectively combined with other therapies, including hormones," said Arlen. "There appears to be an advantage in overall survival."

Arlen and colleagues enrolled 42 patients who had castration-resistant prostate cancer. These patients were randomly assigned to receive either a poxvirus-based prostate-specific antigen vaccine or hormone therapy with nilutamide. At progression, patients received the other therapy and continued to receive their original therapy.

For all the patients enrolled in the study, the three-year survival probability was 71 percent and the median overall survival was 4.4 years. Patients randomized to the vaccine had a three-year survival probability of 81 percent and an overall survival of 5.1 years, while patients taking nilutamide had a three-year survival probability of 62 percent and an overall survival of 3.4 years.

Of the 42 patients in the study, 12 patients who were originally assigned to vaccine switched to nilutamide plus vaccine and eight patients who were originally assigned to nilutamide switched to vaccine plus hormone, due to rising levels of prostate-specific antigen with no evidence of metastasis. For patients who received vaccine and then nilutamide, the three-ye
'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Counting tumor cells in blood predicts treatment benefit in prostate cancer
2. Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence
3. Certain form of tomatoes could be key to prostate cancer prevention
4. Estrogen helps drive distinct, aggressive form of prostate cancer
5. Genes may play role in risk assessment for prostate cancer among Hispanics and caucasians
6. Biomarker predicts malignancy potential of HG-PIN lesions in the prostate
7. Potential association of type 2 diabetes genes with prostate cancer
8. New, noninvasive prostate cancer test beats PSA in detecting prostate cancer
9. Prostate cancer: Watchful wait or vaccinate?
10. Nanomedicine research for prostate cancer supported by $5 million gift
11. Safeway Inc. and PCF to fund landmark prostate cancer research collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ve easy lives. In addition to mammalian immune sys...ies called bacteriophages, viruses that kill half ...bacteria and another class of microorganisms calle...s such as deep-sea volcanic vents) manage just fin... defense system that helps protect them from many ...
(Date:11/25/2009)... Soil is the linchpin of the environment, where a...e that, many students see soil as "just dirt" a p...e educators are challenged with the task of helpin...mportance of soil in the environment. , A colla... teachers at University of Nebraska-Lincoln, Orego...
(Date:11/25/2009)... be just as vital to your health as what you eat, ...ical Studies. Their experiments in mice revealed t...nes in the liverthe body,s metabolic clearinghouse... body,s circadian clock as conventional wisdom had... of a large number of genes completely independent...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Feeding the clock 2Feeding the clock 3Sequella and NIH Sign Exclusive Worldwide Licensing Agreement for SQ109 for New Infectious Disease Indications 14851 1Sequella and NIH Sign Exclusive Worldwide Licensing Agreement for SQ109 for New Infectious Disease Indications 14851 2Sequella and NIH Sign Exclusive Worldwide Licensing Agreement for SQ109 for New Infectious Disease Indications 14851 3Derma Sciences Files S 1 Registration Statement 6296 1Derma Sciences Files S 1 Registration Statement 6296 2Derma Sciences Files S 1 Registration Statement 6296 3QRxPharma Limited Announces A 2421 6 Million Fully Underwritten Capital Raising 6291 1QRxPharma Limited Announces A 2421 6 Million Fully Underwritten Capital Raising 6291 2QRxPharma Limited Announces A 2421 6 Million Fully Underwritten Capital Raising 6291 3QRxPharma Limited Announces A 2421 6 Million Fully Underwritten Capital Raising 6291 4
...the zebrafish (Danio rerio) develops one of its fo...ist of tasks carried out by an important molecule ...from nerve cells to reproductive cells in the deve...ular zebrafish mutant known as choker, which is di...down its side is missing, and it has a dark collar...
...echnology that can in one fell swoop decode 50 mil...ses of DNA, a research team led by University of D... and how certain genes are switched on or off in r...he goal of the four-year project, which is support...ce Foundation (NSF), is to advance scientific unde...
...ill donate $120,000 to the Duluth-based Internatio...rther its important work aimed at improving toxici...mals who are routinely maimed and killed in labora...he McKim Conference tomorrow, September 25, at the...Conference provides a stimulating environment for ...
Other Biology News:Study shows how the zebrafish gets his stripe 2UD leads $5.3-million research project on rice epigenetics 2UD leads $5.3-million research project on rice epigenetics 3UD leads $5.3-million research project on rice epigenetics 4PETA awards $120,000 to Duluth Foundation for advancing non-animal tests 2
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--ArdeaBiosciences,In...arm.D.,presidentandchiefexecutiveofficer,willprese... , ,Presentationdetailsareasfollows:,PiperJaffra...ber1,2009,Time:2:00p.m.EasternTime,Location:TheNew...www.corporate-ir.net/ireye/,target=,_blank,title=...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC ),a...nssystemsandservicesforthecommercial,industrialand...businessgrouphasbeenawardedacontractfromManhattanT...o-safetylab(BSL-4)replacementfacilityattheU.S.Army...IID)atFortDetrickinFrederick,Md. ,, ThenewUSAMR...
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
(Date:11/24/2009)...ndBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--D...assetsofHylandSeeds,adivisionofThompsonsLimitedofB...rexpandDowAgroSciences,currentseedsbusinessastheco... 2010 andDowAgroSciencesHerbicideTolerantTraitTe...edinthenearfuture. ,, "Thisacquisitionbringstog...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...Health,Inc. (Nasdaq: GHDX ) today announced that ...Chief Executive Officer, will present at the BIO,I...11, 2007 at 3:00 p.m.,Pacific Time. To access the...sentation, visit the Investor Relations section of...michealth.com . Please connect to the website,at l...
...harmaceuticals, Inc. (Nasdaq: MLNM ) today announ..., to its Board of Directors. Dr. Leiden, a,Managin...ture capital firm,has a distinguished career of mo...nd pharmaceutical sectors. Prior to joining Clarus...ng Officer of the Global,Pharmaceutical Business o...
...edical,(TASE: TOPMD), the developer of a unique te...cular MRI (IVMRI) catheter for the coronary arteri... President and Chief,Executive Officer. Yaron Tal ...serve as a board member and consultant to the comp...ed the company from the,initial development stage....
Other Biology Technology:Genomic Health to Present at BIO InvestorForum 2007 2Life Sciences Leader Joins Millennium Board of Directors 2Life Sciences Leader Joins Millennium Board of Directors 3Top Spin Appoints Yaron Tal President and Chief Executive Officer, Erez Golan, TopSpin Medical's Founder and Current Chief Executive Officer, Will Continue as a Board Member and Consultant 2Top Spin Appoints Yaron Tal President and Chief Executive Officer, Erez Golan, TopSpin Medical's Founder and Current Chief Executive Officer, Will Continue as a Board Member and Consultant 3
Mouse Anti-Cystatin A Monoclonal Antibody, Unconjugated, Clone WR-23/2/3/3 from Sigma-Aldrich
...kit provides all the accessories necessary for cas...d conformation polymorphism analysis (SSCP) with t...kit includes a cooling finger adaptor for use with...cm plates, 2 sets of 0.75 mm spacers, two 20-well ...
...ns analysis kit for 25 chips provides the chips an...y RNA analysis (at nanogram levels) with the Exper...ludes 25 RNA StdSens microfluidic chips, 2 x 1,250...ns stain, 2 x 20 microliters RNA ladder, 2 x 900 m...
...rocapillary flow cytometry accessible to anyone in... the latest addition to Guavas on-demand cytometry...sing affordable, and very compact for higher throu...such features as absolute cell counts, 6 parameter...
Biology Products: